Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Invested Capital (2020 - 2025)

Immatics (IMTX) posted Invested Capital of $20.1 million for Q3 2022, down 34.29% sequentially from $30.7 million in Q2 2022, and down 34.93% YoY from $31.0 million in Q3 2021.

Analysis

Immatics (IMTX) Invested Capital (2020 - 2025) Analysis & Trends

Immatics has reported Invested Capital for 4 years, with the latest figure at $20.1 million in Q3 2022.

  • Quarterly Invested Capital fell 34.93% year-over-year to $20.1 million in Q3 2022, while the trailing twelve-month figure through Jun 2023 was $20.1 million (down 83.26% YoY) and the FY2021 annual result came in at $47.6 million, up 49.47% from the prior year.
  • Invested Capital fell to $20.1 million in Q3 2022 per IMTX's latest filing, from $30.7 million in the prior quarter.
  • Over five years, Invested Capital peaked at $162.2 million in Q1 2020 and troughed at $9.3 million in Q4 2019.
  • A 4-year average of $40.5 million and a median of $30.8 million in 2021 frame the typical range for Invested Capital.
  • The sharpest annual moves came in 2020 and 2021: Invested Capital soared 258.83% in 2020, then slumped 86.55% in 2021.
  • Over 4 years, Invested Capital stood at $9.3 million in 2019, then jumped by 258.83% to $33.2 million in 2020, then soared by 38.37% to $46.0 million in 2021, then slumped by 56.2% to $20.1 million in 2022.
  • According to Business Quant data, Invested Capital over the past three periods registered $20.1 million, $30.7 million, and $12.7 million for Q3 2022, Q2 2022, and Q1 2022 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 33.70 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 7.35 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 6.25 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.13 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.30 Bn
10 Immatics 1.17 Bn 711.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 562.41 Mn
Sep 30, 2022 134.13 Mn
Jun 30, 2022 148.38 Mn
Mar 31, 2022 142.89 Mn
Dec 31, 2021 59.40 Mn
Sep 30, 2021 72.43 Mn
Dec 31, 2020 124.30 Mn
Mar 31, 2020 162.17 Mn